Envista Corp
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeuti...
Latest News
4 days ago · zacks.com
Envista Q3 Earnings Ahead: Product Innovation to Drive GrowthEnvista NVST is scheduled to release third-quarter 2026 results on Nov. 4, after the closing bell.
4 days ago · zacks.com
Envista (NVST) Earnings Expected to Grow: Should You Buy?Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 days ago · prnewswire.com
Envista Announces Release of 2025 Sustainability ReportBREA, Calif., Oct. 27, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced the publication of its 2025 Sustainability Report.
24 days ago · zacks.com
Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
25 days ago · zacks.com
Here's Why Envista (NVST) is a Strong Growth StockWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
26 days ago · fool.com
Recently Appointed Cooper Companies Director Paul Keel Buys $250,000 Stock. Does This Signal Shares are a Buy?Keel purchased 4,701 shares at $53.18 each following a 21% year-long decline, signaling confidence in the medical device company's valuation.
27 days ago · prnewswire.com
Envista Schedules Third Quarter 2026 Earnings CallBREA, Calif., Oct. 6, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2026 on Wednesday, November 4, 2026.
1 month ago · zacks.com
NVST vs. ABT: Which Stock Is the Better Value Option?Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
1 month ago · zacks.com
Should Value Investors Buy Envista (NVST) Stock?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
1 month ago · zacks.com
Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)Envista (NVST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove NVST